Litcius/Paper detail

Cetuximab-based PROteolysis targeting chimera for effectual downregulation of NSCLC with varied EGFR mutations

Richa Vartak, Bhavesh Deore, Carlos Sanhueza, Ketan Patel

2023International Journal of Biological Macromolecules32 citationsDOIOpen Access PDF

Topics & Concepts

CetuximabChemistryEpidermal growth factor receptorUbiquitin ligaseCancer researchBiochemistryReceptorAntibodyUbiquitinBiologyMonoclonal antibodyImmunologyGeneProtein Degradation and InhibitorsPeptidase Inhibition and AnalysisHER2/EGFR in Cancer Research
Cetuximab-based PROteolysis targeting chimera for effectual downregulation of NSCLC with varied EGFR mutations | Litcius